PRAMIPEXOL SANDOZ 3.15mg prolonged-release tablets medication leaflet

N04BC05 pramipexole • Nervous system | Dopaminergic agents | Dopamine agonists

Pramipexole is a dopamine receptor agonist used for the treatment of Parkinson's disease and restless legs syndrome. It works by stimulating dopamine receptors in the brain, alleviating motor and non-motor symptoms.

The medication is taken orally, as directed by a doctor, usually once to three times daily. It is important for patients to follow the treatment regimen and inform the doctor about any other medications being used.

Patients should be aware of potential side effects, such as drowsiness, dizziness, or nausea. It is important to inform the doctor of any unusual symptoms.

Common side effects include drowsiness, dizziness, and nausea. In rare cases, severe reactions such as hallucinations or compulsive behaviors may occur. Patients should be informed of these risks before use.

General data about PRAMIPEXOL SANDOZ 3.15mg

Substance: pramipexole

Date of last drug list: 01-08-2019

Commercial code: W66162001

Concentration: 3.15mg

Pharmaceutical form: prolonged-release tablets

Quantity: 10

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: FERRER INTERNACIONAL, S.A. - SPANIA

Holder: S.C. SANDOZ S.R.L. - ROMANIA

Number: 6751/2014/01

Shelf life: 30 months

Pharmaceutical forms available for pramipexole

Concentrations available for pramipexole

0.088mg, 0.18mg, 0.26mg, 0.35, 0.35mg, 0.52mg, 0.54mg, 0.70mg, 0.7mg, 1.05mg, 1.1mg, 1.57mg, 2.10mg, 2.1mg, 2.62mg, 3.15mg